Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_assertion type Assertion NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_head.
- NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_assertion wasGeneratedBy ECO_0000203 NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_provenance.
- NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_assertion wasDerivedFrom befree-2016 NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_provenance.
- NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_assertion SIO_000772 19675582 NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_provenance.
- NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_assertion evidence source_evidence_literature NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_provenance.
- NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_assertion description "[Complement activation in myasthenia gravis (MG) may damage muscle endplate and complement regulatory proteins such as decay-accelerating factor (DAF) or CD55 may be protective.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757277.RAF3CeS_khJTRFS3_ViUDIjQm6DACVZlFTpKZv7DOO_sU130_provenance.